Scleroderma

DBCOND0013449Immune System DiseasesMusculoskeletal and Connective Tissue Diseases

Scleroderma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Systemic Sclerosis (Scleroderma) · Systemic Sclerosis, Scleroderma · Systemic Sclerosis [Scleroderma]
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10M34SNOMED CT128457007MedDRA10012517UMLSC0011644

What you can answer from here — as of November 15, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
83Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
5Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Scleroderma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In